Literature DB >> 31076186

Functional remediation improves bipolar disorder functioning with no effects on brain-derived neurotrophic factor levels.

Caterina Del Mar Bonnin1, Elia Valls1, Adriane R Rosa2, Maria Reinares1, Esther Jimenez1, Brisa Solé1, Laura Montejo1, Ana Meseguer3, Isabella Pacchiarotti1, Francesc Colom4, Anabel Martinez-Aran5, Yoko Tomioka1, Eduard Vieta1, Carla Torrent1.   

Abstract

The main aim of this study is to evaluate the impact of functional remediation (FR) in serum brain derived neurotrophic factor (BDNF) levels in euthymic adult patients with Bipolar Disorder (BD). A total of 128 participants were recruited at the Hospital Clinic of Barcelona. They were assessed at baseline and at the end of follow-up by the means of Hamilton Depression Scale (HAM-D), Young Mania Rating Scale (YMRS) and Functioning Assessment Short Test (FAST), as well as a clinical structured interview to collect clinical and demographic variables of interest. Blood samples were also collected to assess BDNF levels. After baseline assessment, patients received FR, Psychoeducation or treatment as usual (TAU). One hundred and two out of 126 participants finished the study distributed as follows: FR group (n = 39); Psychoeducation group (n = 47) and TAU group (n = 16). Longitudinal repeated-measures analyses addressing the treatment effect on BDNF levels showed non-significant differences between the three groups (Pillai's trace = 0.06; F(2,97)= 0.28; p = 0.75), suggesting no interaction between treatment allocation and time on BDNF levels. The results of this study suggest that FR has no effect on peripheral BDNF levels in euthymic patients with BD, despite the improvement in psychosocial functioning.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  BDNF; Bipolar disorder; Functional remediation; Functioning; Psychoeducation

Mesh:

Substances:

Year:  2019        PMID: 31076186     DOI: 10.1016/j.euroneuro.2019.04.002

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  1 in total

Review 1.  Neurocognitive impairment and evidence-based treatment options in Bipolar disorder.

Authors:  Konstantinos N Fountoulakis
Journal:  Ann Gen Psychiatry       Date:  2020-09-23       Impact factor: 3.455

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.